Chana L. Glasser

Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience

P. Pallavi Madhusoodhan, Joanna Pierro, Jordan Musante et al. · Pediatric Blood & Cancer · 2020 · 118 citations · Full text

Medicine, Oncology, Pediatrics +13

Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

Zachary Miklja, Viveka Nand Yadav, Rodrigo T. Cartaxo et al. · Journal of Clinical Investigation · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience

Lianna J. Marks, Jennifer A. Oberg, Danielle Pendrick et al. · Frontiers in Pediatrics · 2017 · 50 citations · Full text

Medicine, Hematology, Pediatrics +17

Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience

Sylwia Jasinski, Mark E. Weinblatt, Chana L. Glasser · Journal of Pediatric Hematology/Oncology · 2017 · 44 citations

Medicine, Hematology, Pediatrics +15

Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation

Chana L. Glasser, Joseph A. Picoraro, Preti Jain et al. · Journal of Pediatric Hematology/Oncology · 2016 · 14 citations

Life Sciences, Genetics, Molecular Genetics +17